{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:53:26Z","timestamp":1791320006086,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpsychires.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:36:06Z","timestamp":1786635366000},"page":"160-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Can fluoxetine's diminished efficacy in pediatric depression be explained by study sites, baseline severity, age, and psychological interventions? A secondary exploratory meta-regression"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-9314","authenticated-orcid":false,"given":"Martin","family":"Pl\u00f6derl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5522-4679","authenticated-orcid":false,"given":"Richard","family":"Lyus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.08.018_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e813","article-title":"Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study","volume":"344","author":"Bafeta","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2008.08020247","article-title":"Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder","volume":"166","author":"Bridge","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105149","article-title":"The future of child and adolescent clinical psychopharmacology: a systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications","volume":"149","author":"Cortese","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib4","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1017\/S0033291718001873","article-title":"The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression","volume":"48","author":"de Vries","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/cap.2015.0192","article-title":"Placebo response in pediatric anxiety disorders: implications for clinical trial design and interpretation","volume":"26","author":"Dobson","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib6","series-title":"Clinical Study Summary: Study B1Y-MC-HCCJ","year":"1986"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JRS-210034","article-title":"Restoring the two pivotal fluoxetine trials in children and adolescents with depression","volume":"33","author":"G\u00f8tzsche","year":"2022","journal-title":"Int. J. Risk Saf. Med."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib9","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","author":"Hetrick","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib10","article-title":"A Re-Appraisal of three network meta-analyses to explain the discrepancy in findings for the efficacy of fluoxetine for the treatment of depression in children and adolescents","author":"Lyus","year":"2025","journal-title":"medRxiv 2025.09.07.25334757"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00787-018-1244-7","article-title":"Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis","volume":"29","author":"Meister","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib12","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1086\/730383","article-title":"Funding of clinical trials and reported drug efficacy","volume":"132","author":"Oostrom","year":"2024","journal-title":"J. Polit. Econ."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.112016","article-title":"The loss of efficacy of fluoxetine in pediatric depression: explanations, lack of acknowledgment, and implications for other treatments","volume":"189","author":"Pl\u00f6derl","year":"2026","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib14","article-title":"Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis","volume":"378","author":"Stone","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/cap.2023.0089","article-title":"Response to Pl\u00f6derl et al. re: \u201cA Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.\u201d","volume":"34","author":"Strawn","year":"2024","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jclinepi.2013.05.016","article-title":"Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review","volume":"66","author":"Unverzagt","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2026.08.018_bib17","series-title":"Rutter's Child and Adolescent Psychiatry and Psychology","first-page":"898","article-title":"Depressive disorders in children and adolescents","author":"Walkup","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib18","series-title":"The great psychotherapy debate: the evidence for what makes psychotherapy work","author":"Wampold","year":"2015"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2026.05.010","article-title":"An individual participant data analysis: optimizing pharmacological treatment in children and adolescents with major depressive disorder","author":"Xiang","year":"2026","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry S0890856726002339"},{"key":"10.1016\/j.jpsychires.2026.08.018_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:10Z","timestamp":1791318550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":20,"alternative-id":["S0022395626004152"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.08.018","relation":{"has-preprint":[{"id-type":"doi","id":"10.31234\/osf.io\/qsdgp_v1","asserted-by":"object"}]},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can fluoxetine's diminished efficacy in pediatric depression be explained by study sites, baseline severity, age, and psychological interventions? A secondary exploratory meta-regression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}